Empirical Wealth Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.27M | Buy |
48,777
+3,608
| +8% | +$422K | 0.09% | 135 |
|
|
2026
Q1 | $5.43M | Buy |
45,169
+7,239
| +19% | +$836K | 0.09% | 140 |
|
|
2025
Q4 | $3.99M | Buy |
37,930
+9,826
| +35% | +$922K | 0.07% | 165 |
|
|
2025
Q3 | $2.36M | Sell |
28,104
-1,390
| -5% | -$114K | 0.05% | 223 |
|
|
2025
Q2 | $2.33M | Sell |
29,494
-4,811
| -14% | -$382K | 0.05% | 215 |
|
|
2025
Q1 | $3.08M | Sell |
34,305
-2,908
| -8% | -$272K | 0.08% | 169 |
|
|
2024
Q4 | $3.7M | Buy |
37,213
+2,660
| +8% | +$274K | 0.1% | 136 |
|
|
2024
Q3 | $3.92M | Buy |
34,553
+3,250
| +10% | +$386K | 0.11% | 135 |
|
|
2024
Q2 | $3.88M | Buy |
31,303
+9,853
| +46% | +$1.27M | 0.11% | 128 |
|
|
2024
Q1 | $2.83M | Sell |
21,450
-570
| -3% | -$70.3K | 0.09% | 143 |
|
|
2023
Q4 | $2.4M | Sell |
22,020
-258
| -1% | -$26.8K | 0.08% | 151 |
|
|
2023
Q3 | $2.29M | Buy |
22,278
+4,523
| +25% | +$488K | 0.09% | 147 |
|
|
2023
Q2 | $2.05M | Buy |
17,755
+1,008
| +6% | +$114K | 0.08% | 154 |
|
|
2023
Q1 | $1.78M | Buy |
16,747
+483
| +3% | +$52.1K | 0.08% | 154 |
|
|
2022
Q4 | $1.8M | Buy |
16,264
+646
| +4% | +$66K | 0.09% | 146 |
|
|
2022
Q3 | $1.34M | Buy |
15,618
+528
| +3% | +$47.1K | 0.07% | 167 |
|
|
2022
Q2 | $1.38M | Buy |
15,090
+2,952
| +24% | +$262K | 0.07% | 171 |
|
|
2022
Q1 | $996K | Sell |
12,138
-2,499
| -17% | -$197K | 0.05% | 214 |
|
|
2021
Q4 | $1.12M | Buy |
14,637
+1,419
| +11% | +$113K | 0.06% | 191 |
|
|
2021
Q3 | $993K | Sell |
13,218
-1,639
| -11% | -$125K | 0.06% | 193 |
|
|
2021
Q2 | $1.16M | Buy |
14,857
+522
| +4% | +$38.8K | 0.07% | 170 |
|
|
2021
Q1 | $1.05M | Buy |
14,335
+3,625
| +34% | +$267K | 0.08% | 151 |
|
|
2020
Q4 | $836K | Sell |
10,710
-20,631
| -66% | -$1.58M | 0.06% | 173 |
|
|
2020
Q3 | $2.48M | Sell |
31,341
-5,168
| -14% | -$405K | 0.21% | 67 |
|
|
2020
Q2 | $2.69M | Buy |
36,509
+1,016
| +3% | +$76.5K | 0.25% | 61 |
|
|
2020
Q1 | $2.61M | Buy |
35,493
+4,375
| +14% | +$344K | 0.28% | 54 |
|
|
2019
Q4 | $2.7M | Buy |
31,118
+3,819
| +14% | +$314K | 0.3% | 52 |
|
|
2019
Q3 | $2.19M | Sell |
27,299
-1,689
| -6% | -$135K | 0.27% | 61 |
|
|
2019
Q2 | $2.32M | Buy |
28,988
+887
| +3% | +$67.9K | 0.3% | 51 |
|
|
2019
Q1 | $2.23M | Buy |
28,101
+17,754
| +172% | +$1.33M | 0.32% | 46 |
|
|
2018
Q4 | $754K | Sell |
10,347
-62
| -0.6% | -$4.38K | 0.13% | 94 |
|
|
2018
Q3 | $705K | Buy |
10,409
+3,543
| +52% | +$226K | 0.13% | 94 |
|
|
2018
Q2 | $398K | Buy |
6,866
+1,233
| +22% | +$69.6K | 0.07% | 124 |
|
|
2018
Q1 | $293K | Buy |
5,633
+818
| +17% | +$44.2K | 0.06% | 137 |
|
|
2017
Q4 | $258K | Buy |
4,815
+288
| +6% | +$16K | 0.06% | 126 |
|
|
2017
Q3 | $277K | Buy |
4,527
+102
| +2% | +$6.18K | 0.06% | 112 |
|
|
2017
Q2 | $271K | Buy |
4,425
+416
| +10% | +$25.3K | 0.07% | 113 |
|
|
2017
Q1 | $243K | Buy |
+4,009
| New | +$243K | 0.06% | 114 |
|
|
2016
Q1 | – | Sell |
-4,519
| Closed | -$228K | – | 108 |
|
|
2015
Q4 | $228K | Sell |
4,519
-1,963
| -30% | -$99K | 0.06% | 97 |
|
|
2015
Q3 | $305K | Sell |
6,482
-20
| -0.3% | -$1.06K | 0.07% | 92 |
|
|
2015
Q2 | $353K | Buy |
6,502
+2,319
| +55% | +$130K | 0.08% | 91 |
|
|
2015
Q1 | $229K | Buy |
+4,183
| New | +$237K | 0.05% | 94 |
|
|
2014
Q4 | – | Sell |
-3,737
| Closed | -$211K | – | 102 |
|
|
2014
Q3 | $211K | Buy |
+3,737
| New | +$210K | 0.05% | 100 |
|
|
2014
Q2 | – | Sell |
-4,017
| Closed | -$218K | – | 103 |
|
|
2014
Q1 | $218K | Buy |
+4,017
| New | +$208K | 0.06% | 93 |
|
Other funds holding MRK
ECSS
ATO
Empirical Wealth Management's MRK Position: Q2 2026 in Review
Empirical Wealth Management increased its Merck (MRK) stake by 8% in Q2 2026, buying an estimated $422K and bringing the position to 48,777 shares worth $6.27M. The position accounts for 0.09% of the portfolio, ranked #135.
Empirical Wealth Management first reported a position in MRK in Q1 2014 and has held it in 44 quarters since. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Empirical Wealth Management held 48,777 shares of Merck worth $6.27M as of Q2 2026.
- Empirical Wealth Management bought 3,608 Merck shares in Q2 2026, an estimated $422K.
- Merck made up 0.09% of Empirical Wealth Management's portfolio in Q2 2026, its #135 holding.
- Empirical Wealth Management first reported a position in Merck in Q1 2014 and has held it in 44 quarters since.
- 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.